Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...
The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
The investigators are looking for a better way to prevent cervical cancer. This study is comparing two different methods to...
Study Objective: Compare longitudinal HIV-1 antibody responses among HIV-1 infected participants that either did or did not...
